Small Business

Shree Cement net profit soars over two-fold

Shree Cement today reported over two-fold jump in its net profit for the quarter ended September 30 at Rs 288.91 crore. - India Cements profit up 2% at Rs 137 cr - Cement unlikely to cost more despite coal price hike - Cement industry growth at 11-month low - Shree Cement forays power sector; to invest Rs 1,200cr - Shree despatches 13.81% more in September - ACC to invest Rs 1,400 cr for expansion next yr The company had posted a net profit of Rs 107.49 crore in the corresponding quarter last fiscal, the Kolkata-based firm said in a statement. The total income during the second quarter also soared by 40.81 per cent at Rs 909.61 crore as against Rs 645.97 crore in the year-ago period, it added. On an overall demand scenario of cement in the country, the company said that the industry grew by 12 per cent during the last quarter on account of rising infrastructure spending and revival in real estate sector. "The focus of the government on affordable housing and availability of concessional lending for the same is expected to drive cement demand for housing," Shree Cement said, adding that the strong cement demand factors are likely to continue fueling growth in the sector. The company, however, said with new capacities coming up in the near future, there could have an impact on prices and capacity utilisation.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Govt denies ombudsman for telecom sector
The government today ruled out appointing an ombudsman to redress the complaints of poor mobile telephony services, like call drops, saying state-run BSNL and MTNL were taking effective steps to upgrade technology.
Popular Articles
quick payday loans

N Murthy sells Rs 177 cr Infy stock for VC fund
Nearly three decades after he co-founded Infosys Technologies with six others, N R Narayana Murthy has initiated the first step towards starting a venture capital (VC) fund focused on India. The Infosys Chairman, during the past two days, has offloaded 800,000 shares from his personal holding, to raise about Rs 177 crore.

Taro tells shareholders to keep Sun at bay
Ahead of its upcoming annual general meeting on December 31, 2009, Israeli drug firm Taro Pharmaceutical today asked its shareholders to reject a takeover bid by India"s Sun Pharmaceuticals.